Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours | BMC Cancer | Full Text

Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours | BMC Cancer | Full Text

Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours

Germ cell tumours (GCTs) represent a highly curable malignity as they respond well to cisplatin (CDDP)-based chemotherapy. Nevertheless, a small proportion of GCT patients relapse or do not respond to therapy....

Authors:Zuzana Cierna, Vera Miskovska, Jan Roska, Dana Jurkovicova, Lucia Borszekova Pulzova, Zuzana Sestakova, Lenka Hurbanova, Katarina Machalekova, Michal Chovanec, Katarina Rejlekova, Daniela Svetlovska, Katarina Kalavska, Karol Kajo, Pavel Babal, Jozef Mardiak, Thomas A. Ward…

Citation:BMC Cancer 2020 20:17

Content type:Research article

Published on: 6 January 2020

• ViewFull Text
 
• ViewPDF